Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02705391 · ClinicalTrials.gov registry record
Advanced MR Imaging in Sarcoma Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 49
- Enrollment target
NCT02705391: Completed study, sponsored by Mayo Clinic.
NCT02705391 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02705391 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
We intend to investigate the clinical application of two emerging imaging modalities for which the technical capability is currently in place at Mayo Clinic. The treatment of Ewing Sarcoma (ES), Rhabdomyosarcoma (RMS) and soft tissue sarcoma (STS) patients on this study will involve multi-disciplinary contributions from nationally recognized sarcoma experts in Radiation Oncology, Radiology, Orthopedic Surgery, Pediatric Oncology, Medical Oncology and Pathology. Patients will undergo additional magnetic resonance (MR) imaging at the same time as the standard imaging. The ability to compare several imaging modalities within a single cohort of patients maximizes the potential of the study to impact the future management of sarcoma patients. The collaborative nature of this study, with essential contributions from many departments will undoubtedly improve the coordinated care of sarcoma patients and naturally disseminate the advanced imaging experience that is acquired.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-02-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02705391
The ClinicalTrials.gov registry entry for NCT02705391 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02705391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02705391 about?
NCT02705391 is a clinical study titled "Advanced MR Imaging in Sarcoma Patients". We intend to investigate the clinical application of two emerging imaging modalities for which the technical capability is currently in place at Mayo Clinic. The treatment of Ewing Sarcoma (ES), Rhabdomyosarcoma (RMS) and soft tissue sarcoma (STS) patients on this study will involve multi-disciplina...
What is the current status of trial NCT02705391?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2016-03. Estimated completion is 2019-02-04.
Who is sponsoring clinical trial NCT02705391?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.